These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30391203)

  • 41. Palmitoylethanolamide in CNS health and disease.
    Mattace Raso G; Russo R; Calignano A; Meli R
    Pharmacol Res; 2014 Aug; 86():32-41. PubMed ID: 24844438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
    Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
    Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands.
    Fidaleo M; Fanelli F; Ceru MP; Moreno S
    Curr Med Chem; 2014; 21(24):2803-21. PubMed ID: 24606520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 Receptor.
    Fonnesu R; Thunuguntla VBSC; Veeramachaneni GK; Bondili JS; La Rocca V; Filipponi C; Spezia PG; Sidoti M; Plicanti E; Quaranta P; Freer G; Pistello M; Mathai ML; Lai M
    Viruses; 2022 May; 14(5):. PubMed ID: 35632821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice.
    Di Paola R; Impellizzeri D; Mondello P; Velardi E; Aloisi C; Cappellani A; Esposito E; Cuzzocrea S
    Shock; 2012 Oct; 38(4):356-66. PubMed ID: 22772472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
    Romero TR; Pacheco Dda F; Duarte ID
    Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice.
    Donvito G; Bagdas D; Toma W; Rahimpour E; Jackson A; Meade JA; AlSharari S; Kulkarni AR; Ivy Carroll F; Lichtman AH; Papke RL; Thakur GA; Imad Damaj M
    Exp Neurol; 2017 Sep; 295():194-201. PubMed ID: 28606623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα.
    Karwad MA; Macpherson T; Wang B; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
    FASEB J; 2017 Feb; 31(2):469-481. PubMed ID: 27623929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-inflammatory effect of palmitoylethanolamide on human adipocytes.
    Hoareau L; Buyse M; Festy F; Ravanan P; Gonthier MP; Matias I; Petrosino S; Tallet F; d'Hellencourt CL; Cesari M; Di Marzo V; Roche R
    Obesity (Silver Spring); 2009 Mar; 17(3):431-8. PubMed ID: 19131941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma.
    Esposito E; Cuzzocrea S
    Mini Rev Med Chem; 2013 Feb; 13(2):237-55. PubMed ID: 22697514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between serum BDNF levels and maternal perinatal depression: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD.
    Mandolini GM; Lazzaretti M; Delvecchio G; Bressi C; Soares JC; Brambilla P
    J Affect Disord; 2020 Jan; 261():271-276. PubMed ID: 31416610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats.
    ; De Filippis D; D'Amico A; Cipriano M; Petrosino S; Orlando P; Di Marzo V; Iuvone T
    Pharmacol Res; 2010 Apr; 61(4):321-8. PubMed ID: 19931394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
    Romero TR; Resende LC; Guzzo LS; Duarte ID
    Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic?
    Lambert DM; Di Marzo V
    Curr Med Chem; 1999 Aug; 6(8):757-73. PubMed ID: 10469890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.
    Skaper SD; Facci L; Barbierato M; Zusso M; Bruschetta G; Impellizzeri D; Cuzzocrea S; Giusti P
    Mol Neurobiol; 2015 Oct; 52(2):1034-42. PubMed ID: 26055231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α.
    Raso GM; Esposito E; Vitiello S; Iacono A; Santoro A; D'Agostino G; Sasso O; Russo R; Piazza PV; Calignano A; Meli R
    J Neuroendocrinol; 2011 Jul; 23(7):591-600. PubMed ID: 21554431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors.
    Farquhar-Smith WP; Jaggar SI; Rice AS
    Pain; 2002 May; 97(1-2):11-21. PubMed ID: 12031775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endocannabinoids in the treatment of mood disorders: evidence from animal models.
    Bambico FR; Duranti A; Tontini A; Tarzia G; Gobbi G
    Curr Pharm Des; 2009; 15(14):1623-46. PubMed ID: 19442178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression.
    Crupi R; Paterniti I; Ahmad A; Campolo M; Esposito E; Cuzzocrea S
    CNS Neurol Disord Drug Targets; 2013 Nov; 12(7):989-1001. PubMed ID: 23844686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential Bioregulator.
    Manzo E; Schiano Moriello A; Tinto F; Verde R; Allarà M; De Petrocellis L; Pagano E; Izzo AA; Di Marzo V; Petrosino S
    Cells; 2021 Feb; 10(2):. PubMed ID: 33672574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.